Prevalence and risk of gingival enlargement in patients treated with nifedipine

Journal of Periodontology

Volumn 72, Issue 5, 2001, Pages 605-611

  Miranda, Jaume ^a   Brunet, Lluis ^a   Roset, Pere ^b   Berini, Leonardo ^b   Farré, Magí ^b   Mendieta, Carlos ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

Cross sectional studies; Gingival hyperplasia epidemiology; Nifedipine adverse effects; Risk factors

Indexed keywords

NIFEDIPINE;

ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; GINGIVA HYPERPLASIA; GINGIVITIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CALCIUM CHANNEL BLOCKERS; CROSS-SECTIONAL STUDIES; DENTAL PLAQUE INDEX; FEMALE; GINGIVA; GINGIVAL OVERGROWTH; GINGIVAL POCKET; GINGIVITIS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NIFEDIPINE; ODDS RATIO; PERIODONTAL INDEX; PREVALENCE; RISK FACTORS; STATISTICS; TIME FACTORS; VASODILATOR AGENTS;

EID: 0035008766     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.5.605     Document Type: Article

References (86)

1. Brunet LI, Miranda J, Farré M, Berini L, Mendieta C. Gingival enlargement induced by drugs. Drug Safety 1996; 15:219-231.
2. Carranza FA. Gingival enlargement. In: Carranza FA, ed. Glickman's Clinical Periodontology. Philadelphia: W.B. Sanders Co.; 1990:125-148.
3. Hassell TM. Local and systemic actions of drugs and other chemical agents on periodontal tissues. In: Genco RJ, Goldman HM, Cohen DW, eds. Contemporary Periodontics. St. Louis: The CV Mosby Co.; 1990:269-276.
4. Mendieta C. Classification of periodontal diseases. Avances Odontoestomatologia 1995;11(Suppl. B):135-143.
5. Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin hyperplasia. Oral Surg Oral Med Oral Pathol 1972;34:898-906.
6. Kimball OP. The treatment of epilepsy with sodium diphenylhydantoinate. JAMA 1939;112:1244-1245.
7. Penarrocha M, Bagan JV, Antolina MM, Alfaro A. Gingival enlargement induced by phenytoin. Revista Europea Odontoestomatología 1989;1:41-48.
8. Adams D, Davies G. Gingival hyperplasia induced by cyclosporin A. A report of two cases. Br Dent J 1984; 157:89-90.
9. Bennett JA, Christian JM. Cyclosporine-induced gingival hyperplasia: Case report and literature review. J Am Dent Assoc 1985;111:272-273.
10. Britton S, Palacios R. Cyclosporin A - usefulness, risks and mechanism of action. Immunol Rev 1982;65:5-21.
11. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: Old problem, new problem. Crit Rev Oral Biol Med 1991; 2:103-137.
12. Hefti AF, Eshenaur AE, Hassell TM, Stone C. Gingival overgrowth in cyclosporine A treated multiple sclerosis patients. J Periodontol 1994;65:744-749.
13. Rateitschak-Plüss E, Hefti A, Loertscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
14. Morisaki I, Akiyama YM, Miyawaki YN, Mori Y. Positive correlation between blood cyclosporin A level and severity of gingival overgrowth in rats. J Periodontol 1997;68: 7-11.
15. Somacarrera ML, Hernández G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65:671-675.
16. Wondimu B, Sandberg J, Modéer T. Gingival overgrowth in renal transplant patients administered cyclosporin A in mixture or in capsule form. A longitudinal study. Clin Transplant 1996;10:71-76.
17. Bullón P, Machuca G, Martinez-Sahuquillo A, Rios JV, Rojas J, Lacalle JR. Clinical assessment of gingival hyperplasia in patients treated with nifedipine. J Clin Periodontol 1994;21:256-259.
18. Carranza FA Jr. Endocrinologic influences on the periodontium. In: Carranza FA Jr., ed. Glickman's Clinical Periodontology. Philadelphia: W.B. Saunders Co.; 1990: 444-459.
19. Lederman D, Lummermann M, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Oral Surg Oral Med Oral Pathol 1984;57:620-622.
20. Lucas RM, Howell L, Wall B. Nifedipine-induced gingival hyperplasia: A histochemical and ultrastructural study. J Periodontol 1985;56:211-215.
21. Ramon Y, Behar S, Kishon Y, Engelberg I. Gingival hyperplasia caused by nifedipine. A preliminary report. Int J Cardiol 1984;5:195-204.
22. Seymour RA. Calcium channel blockers and gingival overgrowth. Br Dent J 1991;170:376-379.
23. Cucchi G, Giustianini S, Robustelli F. Gingival hyperplasia caused by verapamil. Ital J Cardiol 1985;15:556-557.
24. Miller CS, Damm DD. Incidence of verapamil-induced gingival hyperplasia in a dental population. J Periodontol 1992;63:453-456.
25. Pernu HE, Oikarinen K, Hietanen J, Knuuttila M. Verapamil-induced gingival overgrowth: A clinical, histologie and biochemic approach. J Oral Pathol Med 1989;18:422-425.
26. Smith M, Glenert CI. Gingival hyperplasia caused by verapamil treatment (in German). Tandlaegebladet 1987;91: 849.
27. Steele RM, Schuna AA, Schreiber RT. Calcium antagonist-induced gingival hyperplasia. Ann Intern Med 1994; 120:663-664.
28. Bowman J, Levy B, Grubb R. Gingival overgrowth induced by diltiazem. Oral Surg Oral Med Oral Pathol 1988;65:183-185.
29. Bullón P, Machuca G, Martínez Sahuquillo A, et al. Clinical assessment of gingival size among patients treated with diltiazem. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:300-304.
30. Colvard MD, Bishop J, Weissman D, Bargiulo AV. Cardizem-induced gingival hyperplasia. Periodont Case Rep 1986;8:67-68.
31. Fattore L, Stablein M, Bredfeldt G, Semla T, Moran M, Doherty-Greenberg JM. Gingival hyperplasia: A side effect of nifedipine and diltiazem. Spec Care Dent 1991;11:107-109.
32. Giustiniani S, Della Cuna FR, Marien M. Hyperplastic gingivitis during diltiazem therapy. Int J Cardiol 1987; 15:247-249.
33. Akimoto Y, Tanaka S, Omata H, et al. Gingival hyperplasia induced by nifedipine. J Nihon Univ Sch Dent 1991;33:174-181.
34. Sooriyamoorthy M, Gower DB. Drug induced gingival overgrowth: Clinical features and possible mechanisms. Med Sci Res 1989;17:881-884.
35. Atilla G, Kütükçuler N. Crevicular fluid interleukin-1β, tumor necrosis factor-α, and interleukin-6 levels in renal transplant patients receiving cyclosporine A. J Periodontol 1998;69:784-790.
36. Fujii A, Kobayashi S. Nifedipine inhibits calcium uptake of nifedipine-sensitive gingival fibroblast. J Dent Res 1990;69(Spec. Issue):332(Abstr. 1789).
37. Fujii A, Matsumoto H, Nakao S, Teshigawara H, Akimoto Y. Effect of calcium-channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders. Arch Oral Biol 1994; 39:99-104.
38. Offenbacher S. Effects of dilantin on monocytic growth factors. J Periodontol 1993;64:237-238.
39. Van der Wall E, Tuinzing D, Hes J. Gingival hyperplasia: A possible side effect of nifedipine. Med Tijdschr Geneeskd 1984;128:1954-1955.
40. Henderson JS, Flynn JC, Tucci MA, et al. Site-specific variations in metabolism by human fibroblasts exposed to nifedipine in vitro. J Oral Pathol Med 1997;26:6-10.
41. Newell J, Irwin CR. Comparative effects of cyclosporin on glycosaminoglycan synthesis by gingival fibroblasts. J Periodontol 1997;68:443-447.
42. Hassell T. Evidence that cyclosporine, phenytoin and dihydropiridines elicit overgrowth by different mechanisms. J Dent Res 1990;69(Spec. Issue)164(Abstr. 447).
43. Pen̄arrocha-Diago M, Bagan-Sebastian JV, Vera-Sempere F. Diphenylhydantoin-induced gingival overgrowth in man: A clinico-pathological study. J Periodontol 1990;61:571-574.
44. Flórez J. Antihypertensive drugs. In: Flórez J, ed. Farmacologia Humana. Barcelona: Ed. Cientificas y Técnicas; 1992:587-589.
45. Tamargo J, Delpón E. Pharmacology of heart failure II. lonotropic and vasodilator drugs. In: Flórez J, ed. Farmacologlía Humana. Barcelona: Ed. Científicas y Técnicas; 1992:549-554.
46. Brown RS, Beaver WT, Bottomley WK. On the mechanism of drug-induced gingival hyperplasia. J Oral 7athol Med 1991;20:201-209.
47. Nagano S, Ogawa T, Fukuyama S, et al. Influence of nicardipine hydrochlorhide on hypotensive effect and insulin secretion in a patient of hypertensive diabetic mellitus. Jpn Pharmacol Ther 1985;19:5309-5313.
48. Pascual-Castroviejo I, Pascual I. Gingival hyperplasia induced by nicardipine. Neurologia 1997;12:37-39.
49. Lombardi T, Fiore-Donno G, Belser U, Di Felice R. Felodipine-induced gingival hyperplasia: A clinical and histologic study. J Oral Pathol Med 1991;20:89-92.
50. Juncadella García E, Fandos Olona JM, Alba Granados J, Descarrega Queralt R. Gingival hyperplasia induced by amlodipine. Med Clin (Spain) 1994;103:358-359.
51. Seymour RA, Ellis JS, Thomason JM, Shibutani J, Nakano Y, Kaneko K. Amlodipine-induced gingival overgrowth. J Clin Periodontol 1994;21:281-283.
52. Jorgensen MG. Prevalence of amlodipine-related gingival hyperplasia. J Periodontol 1997;68:676-678.
53. Bencini PL, Crosti C, Sala F, Ambroso GC, Marini D. Gingival hyperplasia induced by nifedipine. Giorn It Derm Vener 1986;121:29-31.
54. Doria G, Cangemi F, Gulizia M, Lo Giudice P, Circo A. Three cases of gingival hyperplasia during treatment with nifedipine. Minerva Cardioangiol 1990;38:97-100.
55. Tavassoli S, Yamalik N, Çaglâyan F, Çaglâyan G, Eratalay K. The clinical effects of nifedipine on periodontal status. J Periodontol 1998;69:108-112.
56. Moreu G, González-Jaranay M, Gijón JJ, Otero A. Gingival enlargement induced by nifedipine in a population of patients with cardiovascular disease. Clinical study (in Spanish). Arch Odonto Estomatol 1995; 11:249-255.
57. Seymour RA, Smith DG, Turnbull DN. The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985; 12:413-419.
58. Miranda J, Brunei LI, Roset PN, Farré M, Berini L, Mendieta C. Prevalence and risk for gingival enlargement induced by calcium channel blockers (abstract). Int Dent J 1998;48:450.
59. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
60. Quigley GA, Hein JW. Comparative classifying efficiency of normal and power brushing. J Am Dent Assoc 1962; 65:26-29.
61. Listgarten MA. Periodontal probing: What does it mean? J Clin Periodontol 1980;7:165-176.
62. Barclay S, Thomason JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992;19:311-314.
63. Pocock SJ. The size of a clinical trial. In: Pocock SJ, ed. Clinical Trials. A Practical Approach. London: John Wiley & Sons; 1984:123-141.
64. Bencini PL, Crosti C, Sala F, et al. Gingival hyperplasia by nifedipine. Report of a case. Acta Derm Venereol 1985;65:362-365.
65. Sauget P, Monteil RA, Monrad P, Loubiere R, Lapalus P, Haudebourg C. Gingival hyperplasia secondary to the use of calcium antagonists: Analysis. J Biol Buccale 1992;20:25-32.
66. Meirnyska A, Abrahamnyska M, Gotsman M. Nifedipine-induced gingival hyperplasia: Case reports and literature review. Isr J Med Sci 1989;25:453-455.
67. Nery E, Edson R, Lee K, Pruthi V, Watson J. Prevalence of nifedipine-induced gingival hyperplasia. J Periodontol 1995;66:572-578.
68. Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine. Histopathological findings. J Periodontol 1987;58:639-642.
69. Cleary JD. Nifedipine-induced gingival overgrowth. Ann Pharmacother 1997;31:922-923.
70. Miranda J. Gingival dismorphism. A study of prevalence of gingival enlargement in patients treated with calcium channel blockers. [Thesis]. Barcelona, Spain: Universitat de Barcelona; 1997:256-271.
71. Fu E, Nieh S, Wikesjö UME, Fu-Gong L, Shen EC. Gingival overgrowth and dental alveolar alterations: Possible mechanisms of cyclosporin-induced tooth migration. An experimental study in the rat. J Periodontol 1997;68: 1231-1236.
72. Brunei LI. Gingival dismorphism. A study of prevalence of gingival enlargement in patients treated with antiepileptics. [Thesis]. Barcelona, Spain: Universitat de Barcelona; 1998;307 p.
73. Grant RH, Parsonage MJ, Barot MH. Phenytoin-induced gum hypertrophy in patients with epilepsy. Curr Med Res Opin 1988;10:652-655.
74. Slavin J, Taylor J. Cyclosporin, nifedipine, and gingival hyperplasia (letter to the editor). Lancet 1987;2:739.
75. Hassell TM, O'Donnell J, Pearlman J, Tesini D, Murphy T, Best H. Phenytoin-induced gingival overgrowth in institutionalized epileptics. J Clin Periodontol 1984;11:242-253.
76. Kieser JB. Simple pockets surgery: II. Soft tissue resection technique. In: Kieser JB, ed. Periodontics. A Practical Approach. London: Wright; 1990:187-225.
77. Hancock RH, Swan RH. Nifedipine-induced gingival overgrowth. J Clin Periodontol 1992;19:12-14.
78. Modéer T, Dahllöf G, Theorell K. Oral health in non-institutionalized epileptic children with special reference to phenytoin medication. Community Dent Oral Epidemiol 1986;14:165-168.
79. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18: 107-110.
80. Pilloni A, Camargo PM, Carere M, Carranza FA. Surgical treatment of cyclosporine A- and nifedipine-induced gingival enlargement: Gingivectomy versus periodontal flap. J Periodontol 1998;69:791-797.
81. Nishikawa S, Tada H, Hamasaki A, et al. Nifedipine-induced gingival hyperplasia: A clinical and in vitro study. J Periodontol 1991;62:30-35.
82. Westbrook P, Bednarczyk EM, Carlson M, Sheehan H, Bissada NF. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. J Periodontol 1997;68:645-650.
83. Cecchin E, Zanello F, De Marchi S. Treatment of cyclosporine-induced gingival hypertrophy. Ann Intern Med 1997;126:409-410.
84. Wahlström E, Zamora JU, Teichman S. Improvement in cyclosporin-associated gingival hyperplasia with azithromycin therapy. New Engl J Med 1995;332:753-754.
85. Wong W, Hodge MG, Lewis A, Sharpstone P, Kingswood JC. Resolution of cyclosporin-induced gingival hypertrophy with metronidazole (letter to the editor). Lancet 1994;343:986.
86. Nash MM, Zaltzman JS. Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplantation 1998;65: 1611-1615.